![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
https://orcid.org/0000-0001-5008-4132
References
- Ahmed MS, Bhalerao AN. 2017. Active management of third stage of labour with special reference to misoprostol. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6:4744–4747.
- Begley CM, Gyte GML, Devane D, McGuire W, Weeks A, Biesty LM. 2019. Active versus expectant management for women in the third stage of labour. The Cochrane Database of Systematic Reviews 2:CD007412.
- Chong Y-S, Su L-L. 2006. Misoprostol for preventing PPH: some lessons learned. The Lancet 368:1216–1218.
- Cunningham FG, Gant NF, Leveno KJ. 2001. Conduct of normal labor and delivery In: Williams editor. Obstetrics. 21st ed. New York: McGraw-Hill. p. 320–325.
- Fawole AO, Sotiloye OS, Hunyinbo KI, Umezulike AC, Okunlola MA, Adekanle DA, et al. 2011. A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 112:107–111.
- Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, et al. 2018. Uterotonic agents for preventing postpartum haemorrhage: a network meta‐analysis. Cochrane Database of Systematic Reviews 2018:CD011689. Issue
- Gulmezoglu AM, et al. 2012. Active management of the third stage of labour with and without controlled cord traction: a randomised, controlled, non-inferiority trial. The Lancet 12:60206–60202.
- El-Refaey H, Rodeck C. 2003. Post-partum haemorrhage: definitions, medical and surgical management. A time for change. British Medical Bulletin 67:205–217.
- Hofmeyr GJ, Fawole B, Mugerwa K, Godi NP, Blignaut Q, Mangesi L, et al. 2011. Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 112:98–102.
- Jadesimi A, Okonofua FE. 2006. Tackling the unacceptable: Nigeria approves misoprostol for postpartum haemorrhage. The Journal of Family Planning and Reproductive Health Care 32:213–214.
- Kwawukume EY, Emuveyan EE. 2002. Postpartum haemorrhage (PPH) In Comprehensive Obstetrics in the tropics. Ghana: Asante and Hittscher. p. 115–121.
- Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. 2014. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2:CD003249.
- Murphy A, McKenna D, Browne I, Kilgariff E, Flynn C, Kelly S, et al. 2014. Clinical practice guideline-Prevention and management of primary postpastum haemorrhage. Institute of Obstetrician and Gynaecology, Royal College of Physicians of Ireland, Version 1.1, Guideline no. 17.
- Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. 2014. Global causes of maternal death: a WHO systematic analysis. The Lancet. Global Health 2: e323–33–e333.
- Stanton CK, Newton S, Mullany LC, Cofie P, Agyemang CT, Adiibokah E, et al. 2012. Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject™ by peripheral health care providers at home births: design of a community-based cluster-randomized trial. BMC Pregnancy and Childbirth 12:42.
- United States Agency for International Development (USAID). 2008. Prevention of postpartum haemorrhage initiative (POPPHI). Factsheets: uterotonic drugs for the prevention and treatment of postpartum heamorrhage. p. 1–11.
- WHO Reproductive Health Library. 2012. WHO recommendation on the use of uterotonics for the prevention of postpartum haemorrhage during the third stage of labour. The WHO Reproductive Health Library. Geneva: World Health Organization.
- WHO. 2018. WHO recommendations: uterotonics for the prevention of postpartum haemorrhage. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO.
- Widmer M, Blum J, Hofmeyr GJ, Carroli G, Abdel-Aleem H, Lumbiganon P, et al. 2010. Misoprostol as an adjunct to standard uterotonics for treatment of postpartum haemorrhage: a multicentre, double-blind randomized trial. The Lancet 375: 1808–1813.
- World Health Organization. 2012. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva, Switzerland: WHO. Available from: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548502/en/index.html.
- Zhong B. 2009. How to calculate sample size in randomized controlled trial? Journal of Thoracic Disease 1:51–54.
- Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G. 2008. Misoprostol in addition to routine treatment of postpartum haemorrhage: a hospital based randomized-controlled trial in Pakistan. BMC Pregnancy and Childbirth 8:40–48.